TITLE

115 Combination-therapy with neutralizing cyclopeptides and beta-blockers decreases molecular markers of sympathetic activation and reverses cardiomyopathy in beta1-receptor antibody-induced heart failure

AUTHOR(S)
Boivin, V.; Palm, D.; Frost, R.J.; Hein, L.; Angermann, C.E.; Ertl, G.; Lohse, M.J.; Jahns, R.
PUB. DATE
June 2007
SOURCE
European Journal of Heart Failure. Supplements;
SOURCE TYPE
DOC. TYPE
Abstract
ABSTRACT
An abstract of the study "Combination-Therapy With Neutralizing Cyclopeptides and Beta-Blockers Decreases Molecular Markers of Sympathetic Activation and Reverses Cardiomyopathy in Beta1-Receptor Antibody-Induced Heart Failure," by S. Nodari and colleagues is presented.
ACCESSION #
25768207

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics